Ramipril
QGC001-2QG4
Phase 2 small_molecule completed
Quick answer
Ramipril for Myocardial Infarction is a Phase 2 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Quantum Biopharma
- Indication
- Myocardial Infarction
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed